Search

everythinglearnresearchcommunity

for

Search:↓

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

RDW can be a useful marker for inflammation in alopecia areata patients.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

COVID-19 infection may trigger alopecia areata in some patients.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Mirror-image twins can have alopecia areata on opposite sides of their heads.

Trichoscopy is good for telling apart tinea capitis and alopecia areata in kids.